Stephen M. Monroe, Partner
Gretchen S. Swanson, Associate Editor
800-248-1668
203-846-6800
Fax: 203-846-8300
pressreleases@levinassociates.com
Year-End 2006 Health Care
Venture Capital Results Up Again, According to Healthcare Corporate Finance
News
Norwalk, CT, January 11, 2007—For the fourth year in a row,
the total amount of venture capital committed to health care companies grew,
rising to more than $8.6 billion for the year ended December 31, 2006—up
nearly 18%, compared with 2005. The year 2006 produced 463 deals (median
size, $12.5 million), representing an increase in deal volume of nearly 5%
over the previous year, and an increase of 16%, compared with 2004.
“Investments in health care services companies helped drive up the quarterly
and year-end totals, including several deals announced by specialty
providers,” noted Gretchen S. Swanson, Associate Editor.
Health Care Venture Capital Deal and Dollar Volume, Q4:04 to Q4:06
Quarter/Year
Number of Deals
Total Funding, in Billions
Q4:04
97
$1.6
Year-End Total, 2004
399
$6.9
Q1:05
122
$2.0
Q2:05
116
$1.9
Q3:05
97
$1.7
Q4:05
108
$1.7
Year-End Total, 2005
443
$7.3
Q1:06
136
$2.2
Q2:06
97
$2.0
Q3:06
110
$2.2
Q4:06
120
$2.2
Year-End Total, 2006
463
$8.6
Health care services companies procured $959.6 million of venture capital in
34 deals in 2006, the first year in a few years that health care services
companies have announced a significant number of venture capital
investments. Pharmaceutical companies, with the most funding for a single
sector, announced 67 venture capital deals totaling $2.05 billion. “Several
venture-backed pharma companies have been established in the past year to
in-license or acquire a technology, product, product candidate or
portfolio,” remarked Stephen M. Monroe, Managing Editor. Investors also
continued to fund biotechnology companies, which raised $1.7 billion in 107
deals, and biopharmaceutical companies, which raised $1.7 billion in 87
deals. Medical device companies announced the most deals in one sector
during the year, with 123 totaling $1.8 billion. E-health and other health
care companies accounted for the remaining transactions.
For the fourth quarter ended December 31, 2006, health care companies raised
about $2.2 billion, representing close to a 29% increase in dollar volume
over the year-ago quarter. Deal volume was up by about 11%, with 120 deals
announced in Q4:06, compared with 108 in Q4:05. Health care services
companies were responsible for raising the greatest amount of venture
capital in one sector, with $515.2 million spread over 16 deals. Medical
device companies announced 32 deals, the largest number in one sector,
totaling $439.7 million. Pharmaceutical companies announced 19 transactions
that raised $505.7 million. Biotechnology and biopharmaceutical companies
together raised $633.7 million in 38 deals, with e-health and other
companies accounting for the remainder.
The top venture capital firms for the fourth quarter and the year ended
December 31, 2006, based on participation in number of investments, are
listed in the following chart.
Most Active Health Care
Venture Capital Firms
Fourth Quarter, Ended December 31, 2006
Number of Investments
Year Ended December 31, 2006
Number of Investments
MPM Capital
4
Sofinnova Ventures
12
Oxford
Bioscience Partners
4
Novartis Venture Fund
12
Burrill & Company
3
Alta Partners
11
Domain Associates
3
New Enterprise Associates
11
Flagship Ventures
3
HBM Funds
11
Highland Capital Partners
3
3i
Group
10
Nexus Medical Partners
3
Domain Associates
10
Tall Oaks Capital
3
InterWest Partners
10
Thomas, McNerney & Partners
3
Pequot Ventures
9
SV
Life Sciences
3
HealthCare Ventures
9
Village Ventures
3
Healthcare Corporate Finance News (www.hcfnews.com)
reports weekly on financial events in the fast-paced venture capital,
private and public equity, and merger and acquisition markets for health
care companies, and provides subscribers with access to a searchable online
database of health care venture capital deals. This monthly newsletter and
weekly email update is published by Irving Levin Associates, Inc., a leading
financial publisher and source of market intelligence since 1948. For more
information, please call 1-800-248-1668
Since 1948, Irving
Levin Associates, Inc. has been the leading source of information
and investment research on mergers and acquisitions in the
Behavioral Health Care, Biotech, e-Health, Home Health Care,
Hospitals, Laboratories, MRI and Dialysis, Long Term Care, Managed
Care, Medical Devices, Pharmaceuticals, Physician Medical Groups,
Rehabilitation and other health care markets.